Key Factors
-
Dividend shares will be an effective way to generate passive revenue.
-
Traders should be sure that firms are producing ample free money move and earnings to cowl their dividends, ideally with the intention of elevating them sooner or later.
-
Ford’s trailing-12-month dividend yield is round 4.5%, whereas Pfizer’s is round 6.9%.
- 10 shares we like higher than Ford Motor Firm ›
Dividend shares generally is a good technique for buyers searching for a dependable and probably extra predictable stream of passive revenue. Two firms with excessive dividend yields are the longtime automaker Ford Motor Firm (NYSE: F) and the big pharmaceutical firm Pfizer (NYSE: PFE). Ford’s trailing-12-month dividend yield is over 4.5%, whereas Pfizer’s yield is roughly 6.9%.
Nonetheless, excessive dividend yields are sometimes excessive for a selected purpose. The secret is to make sure that firms can cowl their dividend funds and now have room to extend their dividends. Which is the higher dividend inventory: Ford or Pfizer?
The place to speculate $1,000 proper now? Our analyst crew simply revealed what they consider are the 10 finest shares to purchase proper now, once you be a part of Inventory Advisor. See the shares »
Picture supply: Getty Pictures.
Ford: A shaky dividend that appears sustainable for now
One key issue to contemplate when evaluating dividend firms is their capability to constantly pay and lift their dividend over time. Ford has been considerably inconsistent on this regard, having needed to reduce its dividend throughout the Nice Recession and once more in 2020 on the onset of the pandemic. In any other case, the corporate has paid dividends all through this era and even issued particular dividends, equivalent to in 2023, which seem to have compensated for the missed dividends in 2020 and 2021.
Ford has confronted quite a few challenges this 12 months, together with President Donald Trump’s tariffs and a fireplace at considered one of its main suppliers, which has impacted the corporate’s earnings. Within the first three quarters of 2025, Ford has paid out about $2.4 billion in dividends, whereas producing about $2.8 billion in earnings. Earnings are down considerably 12 months over 12 months resulting from among the headwinds talked about above.
Nonetheless, the corporate has generated adjusted free money move of $5.7 billion. Plus, Ford is guiding for one more $2 billion to $3 billion of free money move within the ultimate quarter of the 12 months and for full-year adjusted EBIT (earnings earlier than curiosity and taxes) of $6 billion to $6.5 billion. Ford also needs to get some aid subsequent 12 months from relaxed tariffs impacting automakers and because the firm pivots away from wide-scale electrical car manufacturing to focus extra on worthwhile hybrid autos.
Pfizer: Struggling free money flows anticipated to enhance
Pfizer has been on a extra unsure path since peaking throughout the COVID-19 pandemic, when the corporate proved to be one of many main suppliers of vaccines that helped reopen the economic system. Nonetheless, since then, the inventory has struggled as buyers wrestle with expiring patents and a strong pipeline of medicine that the corporate has acquired by giant acquisitions.
Pfizer is an attention-grabbing dividend firm. It has paid dividends for 87 straight years, however it hasn’t at all times elevated its dividend throughout all of those years. Within the first 9 months of 2025, Pfizer has paid roughly $7.3 billion in dividends, whereas producing $9.4 billion of internet revenue. Nonetheless, I estimate free money move at about $4.6 billion to date by the 12 months.
The corporate just lately issued steerage for 2026 that got here in beneath analyst estimates. Administration partly attributed the subdued steerage to decrease income from the COVID-19 vaccine and Paxlovid, its antiviral tablet.
Nonetheless, administration on the corporate’s most recentearnings callsaid it expects to “generate strong money move from operations in ’26,” and can be targeted on sustaining and rising the dividend. Analysts are additionally forecasting a lot increased free money flows over the following two years, in accordance with estimates offered by Seen Alpha.
Which is the higher dividend inventory?
As dividend shares, each Ford and Pfizer have execs and cons. Pfizer has been paying its dividend for an extended interval, however Ford will sometimes supply particular dividends. Ford’s earnings to date this 12 months have struggled to cowl the dividend, whereas Pfizer’s free money move has didn’t cowl its dividend. In the meantime, the monetary image seems to be enhancing at Ford, and Pfizer additionally seems poised to develop free money move, though its ahead steerage left a lot to be desired.
In the end, each firms ought to be capable to cowl their respective dividends within the close to future; nonetheless, neither is a assure for the long run. I might give a slight edge to Pfizer proper now, given its monitor report, administration’s clear dedication to the dividend, and the upper yield, which higher compensates buyers for the chance.
Must you purchase inventory in Ford Motor Firm proper now?
Before you purchase inventory in Ford Motor Firm, take into account this:
The Motley Idiot Inventory Advisor analyst crew simply recognized what they consider are the 10 finest shares for buyers to purchase now… and Ford Motor Firm wasn’t considered one of them. The ten shares that made the reduce might produce monster returns within the coming years.
Take into account when Netflix made this record on December 17, 2004… if you happen to invested $1,000 on the time of our suggestion, you’d have $490,703!* Or when Nvidia made this record on April 15, 2005… if you happen to invested $1,000 on the time of our suggestion, you’d have $1,157,689!*
Now, it’s price noting Inventory Advisor’s complete common return is 966% — a market-crushing outperformance in comparison with 194% for the S&P 500. Do not miss the newest prime 10 record, out there with Inventory Advisor, and be a part of an investing neighborhood constructed by particular person buyers for particular person buyers.
See the ten shares »
*Inventory Advisor returns as of January 5, 2026.
Bram Berkowitz has no place in any of the shares talked about. The Motley Idiot has positions in and recommends Pfizer. The Motley Idiot has a disclosure coverage.
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.
